|
|
Article: Alcon Makes Leadership Change to Research and Development Organization.
- Article from:
- Health & Beauty Close-Up
- Article date:
- March 12, 2008
CopyrightCOPYRIGHT 2008 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HEALTH AND BEAUTY CLOSE-UP-12 March 2008-Alcon Makes Leadership Change to Research and Development Organization(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com
Alcon announced that Gerald D. Cagle, Ph.D., Alcon s senior vice president of Research and Development and chief scientific officer, will be retiring from the company on June 30 after 32 years of dedicated service.
The company also announced that Sabri Markabi, MD, currently vice president, head of Development Franchise at Novartis Global Development, will succeed Dr. Cagle and join the company as senior vice president of Research and Development on March 27.
Dr. Cagle began his long ...
Related newspaper, magazine, and journal articles:
|
|
Article: Alcon may pay $95 million in dispute over phaco patents
Ophthalmology Times;
June 15, 2005 ;
700+ words
... ... injunction to block Alcon's sales of ... Sheree Aronson, vice president of investor relations ... Elaine Whitbeck, Alcon's vice president and general counsel ... Doug MacHatton, vice president of investor relations ... communications, Alcon, said the company ...
|
|